2784 Alfresa Holdings
- 2184.0
- -20.0-0.91%
Alfresa Holdings News
Alfresa Holdings: Summary of Financial Results for the second quarter 2025
Alfresa Holdings: Notice regarding the Determination of Matters Concerning Share Buyback
Alfresa Holdings: Notice Concerning Decisions on Matters Relating to Repurchase of Treasury Shares
Alfresa Holdings: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3 [Japanese GAAP] (Consolidated)
Alfresa Holdings: Notice regarding personnel changes at subsidiaries
Alfresa Holdings: Notice regarding Revisions to the Consolidated Performance Forecast (Prepared Based on Japan’s Generally Accepted Accounting Principles (GAAP))
Alfresa Holdings: Notice regarding revisions to earnings forecasts
Alfresa Holdings: Investment in “Archetype Ventures No. 3 Investment Limited Partnership”
Alfresa Holdings: Notice regarding personnel changes at subsidiaries
Alfresa Holdings: Corporate Governance Report 2024/09/30
Alfresa Holdings: Change Report (Stock Certificates Eligible for Special Provisions, etc.)
Alfresa Holdings: Notice regarding completion of share acquisition of the newly established split company of INTAGE HEALTHCARE CO., LTD.
Alfresa Holdings: About the construction of a vaccine supply optimization platform using Salesforce products by Alfresa Corporation
Alfresa Holdings: Notice Concerning Organizational Reforms, Executive Changes, and Personnel Changes at Subsidiaries
Alfresa Holdings: Overview of Q1 2025 earnings report.
Alfresa Holdings: First Quarter Financial Results Short Message (Consolidated) for March 2025 [Japanese Standards]
Alfresa Holdings: Alphressa Corporation and Apocrit Corporation are participating in the trial operation of the ReMed recycling project for disposable syringes that contribute to reducing plastic waste.
Alfresa Holdings: Announcements of individual stocks regarding organizational reform at subsidiary companies.
Alfresa Holdings: Announcements of individual stocks regarding organizational reform and personnel changes in the subsidiary.
Alfresa Holdings: Interim report
Analysis
Price Target
No Data
No Data